GLP-1 receptor agonist industry include Novo Nordisk A/S, Eli Lilly and Company, Amneal Pharmaceuticals LLC, Sanofi, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd, Pfizer Inc., Viking Therapeutics, Structure Therapeutics, Inc., Altimmune, Sandoz Group AG, and Biocon
Many patients qualify with a BMI of 27 or higher if they also have one or more weight-related medical conditions
References Davies M, et al
Muscle cramps are sudden and sharp, whereas RLS symptoms are more of a creeping, uncomfortable sensation that improves with movement, but returns once the person is still again